NIJZ’s report on 2024 medicine use records 1,666 prescriptions and 2,091 compounded cannabinoid preparations from reporting pharmacies. Reporting was incomplete, and the report describes flower and standardised extracts as permitted but not yet routinely used.[1]
Listed for context. No score change is recorded for Slovenia here.
References
Checked. The date and the event were compared with a source that was read.